106 related articles for article (PubMed ID: 16612217)
1. Functional magnetic resonance imaging of cholinergic modulation in mild cognitive impairment.
Dickerson BC
Curr Opin Psychiatry; 2006 May; 19(3):299-306. PubMed ID: 16612217
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
Goekoop R; Scheltens P; Barkhof F; Rombouts SA
Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hippocampal function in mild cognitive impairment: targeting the cholinergic hypothesis.
Grön G; Brandenburg I; Wunderlich AP; Riepe MW
Neurobiol Aging; 2006 Jan; 27(1):78-87. PubMed ID: 16298243
[TBL] [Abstract][Full Text] [Related]
4. Decreased activation along the dorsal visual pathway after a 3-month treatment with galantamine in mild Alzheimer disease: a functional magnetic resonance imaging study.
Bokde AL; Karmann M; Teipel SJ; Born C; Lieb M; Reiser MF; Möller HJ; Hampel H
J Clin Psychopharmacol; 2009 Apr; 29(2):147-56. PubMed ID: 19512976
[TBL] [Abstract][Full Text] [Related]
5. Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment.
Griffith HR; Stewart CC; den Hollander JA
Int Rev Neurobiol; 2009; 84():105-31. PubMed ID: 19501715
[TBL] [Abstract][Full Text] [Related]
6. Functional central nervous system imaging in the investigation of obstructive sleep apnea.
Ayalon L; Peterson S
Curr Opin Pulm Med; 2007 Nov; 13(6):479-83. PubMed ID: 17901752
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
8. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
Behl P; Bocti C; Swartz RH; Gao F; Sahlas DJ; Lanctot KL; Streiner DL; Black SE
Arch Neurol; 2007 Feb; 64(2):266-72. PubMed ID: 17296844
[TBL] [Abstract][Full Text] [Related]
9. Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Pilatus U; Lais C; Rochmont Adu M; Kratzsch T; Frölich L; Maurer K; Zanella FE; Lanfermann H; Pantel J
Psychiatry Res; 2009 Jul; 173(1):1-7. PubMed ID: 19427767
[TBL] [Abstract][Full Text] [Related]
10. Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice.
Bekker A; Haile M; Gingrich K; Wenning L; Gorny A; Quartermain D; Blanck T
Anesth Analg; 2007 Sep; 105(3):739-43. PubMed ID: 17717233
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
Campanozzi MD; Casali E; Neviani F; Martini E; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():91-6. PubMed ID: 17317439
[TBL] [Abstract][Full Text] [Related]
12. Concept of functional imaging of memory decline in Alzheimer's disease.
Drzezga A
Methods; 2008 Apr; 44(4):304-14. PubMed ID: 18374274
[TBL] [Abstract][Full Text] [Related]
13. [Neuroimaging in mild cognitive impairment].
Fukuyama H
Rinsho Shinkeigaku; 2006 Nov; 46(11):791-4. PubMed ID: 17432181
[TBL] [Abstract][Full Text] [Related]
14. Using magnetoencephalography to study patterns of brain magnetic activity in Alzheimer's disease.
Criado JR; Amo C; Quint P; Kurelowech L; Otis SM
Am J Alzheimers Dis Other Demen; 2006 Dec-2007 Jan; 21(6):416-23. PubMed ID: 17267374
[TBL] [Abstract][Full Text] [Related]
15. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease.
Solé-Padullés C; Bartrés-Faz D; Junqué C; Vendrell P; Rami L; Clemente IC; Bosch B; Villar A; Bargalló N; Jurado MA; Barrios M; Molinuevo JL
Neurobiol Aging; 2009 Jul; 30(7):1114-24. PubMed ID: 18053618
[TBL] [Abstract][Full Text] [Related]
16. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Rami L; Gómez-Ansón B; Bosch B; Sánchez-Valle R; Monte GC; Villar A; Molinuevo JL
Dement Geriatr Cogn Disord; 2007; 24(4):274-9. PubMed ID: 17717413
[TBL] [Abstract][Full Text] [Related]
17. An fMRI study of verbal episodic memory encoding in amnestic mild cognitive impairment.
Dannhauser TM; Shergill SS; Stevens T; Lee L; Seal M; Walker RW; Walker Z
Cortex; 2008; 44(7):869-80. PubMed ID: 18489966
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
[TBL] [Abstract][Full Text] [Related]
19. Functional abnormalities of the visual processing system in subjects with mild cognitive impairment: an fMRI study.
Bokde AL; Lopez-Bayo P; Born C; Dong W; Meindl T; Leinsinger G; Teipel SJ; Faltraco F; Reiser M; Möller HJ; Hampel H
Psychiatry Res; 2008 Aug; 163(3):248-59. PubMed ID: 18672352
[TBL] [Abstract][Full Text] [Related]
20. Regional brain activity after prolonged cholinergic enhancement in early Alzheimer's disease.
Shanks MF; McGeown WJ; Forbes-McKay KE; Waiter GD; Ries M; Venneri A
Magn Reson Imaging; 2007 Jul; 25(6):848-59. PubMed ID: 17442521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
